Continuous versus intermittent beta-lactam infusion in severe sepsis: a meta-analysis of individual patient data from randomized trials

QR Code

Continuous versus intermittent beta-lactam infusion in severe sepsis: a meta-analysis of individual patient data from randomized trials

Measurements and Main Results: We identified three randomized controlled trials in which researchers recruited a total of 632 patients with severe sepsis. The two groups were well balanced in terms of age, sex, and illness severity. The rates of hospital mortality and clinical cure for the continuou...

Full description

Bibliographic Details
Main Authors:	Roberts, Jason A., Abdul Aziz, Mohd. Hafiz, Davis, Joshua S., Dulhunty, Joel M., Cotta, Menino O., Myburgh, John, Bellomo, Rinaldo, Lipman, Jeffrey
Format:	Article
Language:	English English English
Published:	American Thoracic Society 2016
Subjects:	R Medicine (General) RM Therapeutics. Pharmacology RS Pharmacy and materia medica
Online Access:	http://irep.iium.edu.my/50325/ http://irep.iium.edu.my/50325/10/roberts2016.pdf http://irep.iium.edu.my/50325/16/50325_Continuous%20versus%20intermittent%20beta-lactam_SCOPUS.pdf http://irep.iium.edu.my/50325/22/50325_Continuous%20versus%20intermittent%20beta-lactam%20infusion%20in%20severe%20sepsis_WoS.pdf

Similar Items

Continuous beta-lactam infusion in critically ill patients: the clinical evidence
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2012)

The BLISS study: Beta-Lactam infusion in severe sepsis-randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis in a Malaysian ICU setting
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2015)

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2016)

Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2017)

Continuous infusion vs. bolus dosing: Implications for beta-lactam antibiotics
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2012)

The DALI study: defining antibiotic levels in intensive care unit patients: prolonged infusion of beta-lactam antibiotics in critically ill patients
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2013)

Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis
by: Rhodes, Nathaniel J., et al.
Published: (2018)

Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration
by: Jamal, Janattul-Ain, et al.
Published: (2015)

Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomized controlled trial of continuous infusion versus intermittent bolus administration
by: Jamal, Janattul-Ain, et al.
Published: (2015)

The decisive study: defining beta-lactam concentration in Intensive care unit patients.
by: Mat Nor, Mohd Basri, et al.
Published: (2020)

Plasma & subcutaneous tissue pharmacokinetics of piperacillin in a large cohort of critically ill patients with sepsis
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2014)

CD63 expression on basophils in patients with allergy to beta-lactam antibiotics / Brenda Leecyous
by: Brenda , Leecyous
Published: (2017)

One-Year Survival And Performance Status In Adult Patients With Sepsis, Severe Sepsis, And Septic Shock
by: Alkhalaf, Mustafa Salman M.
Published: (2013)

Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal
by: Osthoff, Michael, et al.
Published: (2016)

Comparison of Pediatric Severe Sepsis Managed in U.S. and European ICUs
by: Giuliano, J., et al.
Published: (2016)

Population pharmacokinetics of doripenem in critically ill patients with sepsis in a Malaysian intensive care unit
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2016)

The DECISIVE Study: defining beta-lactam concentration in intensive care unit patients-the pharmacokinetics of piperacillin and meropenem in critically ill patients with conserved renal function
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2020)

Procalcitonin clearance for early prediction of survival in critically ill patients with severe sepsis
by: Mat Nor, Mohd Basri, et al.
Published: (2014)

The prevalence and beta lactam antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis isolated from healthy adult in IIUM Kuantan Campus
by: Abdul Halim, Nabila Huda, et al.
Published: (2017)

Mechanisms of resistance to β-lactam antibiotics in Bacteroides species
by: Edwards, Richard
Published: (1995)

Elucidating the mechanism of action of novel lactams on Pseudomonas aeruginosa
by: Pantalone, P.
Published: (2019)

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2015)

Modeling of insulin sensitivity for Sepsis-AKI and Sepsis Non-AKI
by: Farhah, M., et al.
Published: (2022)

Blood glucose and sepsis score on sepsis patients requiring insulin therapy
by: Mohamad Suhaimi, Fatanah, et al.
Published: (2018)

Evaluation of pre-treated healthcare wastes during COVID-19 pandemic reveals pathogenic microbiota, antibiotics residues, and antibiotic resistance genes against beta-lactams
by: Siew, Shing Wei, et al.
Published: (2023)

A comparative study of target contolled infusion (TCI) and manual controlled infusion (MCI) of propofol for sedation in severe traumatic brain-injured patient
by: W Hassan, W Mohd Nazaruddin
Published: (2010)

Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study
by: Weiss, S., et al.
Published: (2015)

Early predictive value of procalcitonin to albumin ratio for intensive care unit mortality in severe sepsis patients
by: Manas, Siti Afifah Abd
Published: (2023)

HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)

Surviving sepsis campaign - The Sequel
by: Leslie, Gavin
Published: (2008)

A comparative study of target controlled infusion (TCI) and manual controlled infusion (MCI) of propofol for sedation during cerebral protection in severe traumatic brain injured patient
by: Hassan, Wan Mohd Nazaruddin Wan
Published: (2010)

Antibiotic dosing for multidrug-resistant pathogen pneumonia
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2017)

Accuracy of International classification of diseases, 10th revision codes for identifying severe sepsis in patients admitted from the emergency department
by: Ibrahim, I., et al.
Published: (2012)

Biomarkers approach in the diagnosis and prognosis of sepsis
by: Mahnaz, Irani-Shemirani
Published: (2022)

Parameters Predicting Clinical Sepsis In Neonates
by: Aldelimi, Ahlam Abulqasem
Published: (2015)

A comparative study between a target controlled infusion (TCI) and manual controlled infusion (MCI) of propofol for sedation during cerebral protection in severe traumatic brain injured patients
by: Anuwar, Ahmad
Published: (2008)

On the beta function and the neutrix product of distributions
by: Fisher, Brian, et al.
Published: (1998)

Combination of Vancomycin and ß-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
by: Davis, J., et al.
Published: (2016)

Australian Enterococcal Sepsis Outcome Progamme, 2011.
by: Coombs, Geoffrey, et al.
Published: (2014)

Australian Enterococcal Sepsis Outcome Progamme, 2011
by: Coombs, Geoffrey, et al.
Published: (2014)